Results 181 to 190 of about 62,751 (282)
Proton Pump Inhibitor Use in Patients With Cirrhosis and Its Association With Spontaneous Bacterial Peritonitis. [PDF]
Thomas M, Lanier C, Covert K.
europepmc +1 more source
This study reports photodeposited Pt nanoparticles on WOx nanowires (Pt–WOx (P)) as a bifunctional catalyst for ammonia electrolysis. Strong metal–support interactions promote electron transfer to Pt, lowering the energy barrier of the rate‐determining step and suppressing NOx formation.
Changhyun Lim +9 more
wiley +1 more source
Proton pump inhibitor use and pancreatic risk: evidence from the UK biobank participants and animal experiments. [PDF]
Gao X +13 more
europepmc +1 more source
Ag44 nanoclusters are anchored on the CdS surface via low‐temperature electrostatic deposition. This facilitated the directed migration of electrons at the interface, thereby effectively suppressing the hydrogen evolution reaction and promoting the highly selective reduction of CO2 to carbon monoxide (CO).
Hangmin Xu +9 more
wiley +1 more source
Long-Term Proton Pump Inhibitor Therapy and Risk of Gastric Atrophy and Precancerous Mucosal Changes: A Systematic Review. [PDF]
Khalid A +8 more
europepmc +1 more source
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma.
Le Rhun E +15 more
europepmc +1 more source
Increased rates of proton pump inhibitor deprescription: a retrospective cohort of patients with upper gastrointestinal bleeding requiring endoscopic intervention. [PDF]
Kecskemeti K, Borgaonkar M, McGrath J.
europepmc +1 more source

